Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Ophthalmol Glaucoma. 2024 Jan-Feb;7(1):75-81. doi: 10.1016/j.ogla.2023.07.002. Epub 2023 Jul 11.
The objectives of this study were to conduct a randomized controlled trial testing the effectiveness of a previsit glaucoma video/question prompt list intervention, and to examine the impact on how often providers educate Black patients about glaucoma and glaucoma medication topics during visits.
A randomized controlled trial of a glaucoma question prompt list/video intervention.
Black patients with a diagnosis of glaucoma who are taking 1 or more glaucoma medications and report being nonadherent.
One hundred eighty-nine Black patients with glaucoma were enrolled and assigned to either a usual care or an intervention group where they watched a video emphasizing the importance of asking questions and received a glaucoma question prompt list to complete before clinic visits. Visits were audio-taped and patients were interviewed after visits.
Whether the provider educates about different glaucoma and glaucoma medication topics.
Patients in the intervention group were significantly more likely to ask providers 1 or more questions about glaucoma and its treatment. Providers were significantly more likely to educate intervention patients about their diagnosis (P = 0.001), intraocular pressure (P = 0.03), the likelihood of the need for long-term therapy (P = 0.001), and the physical changes associated with glaucoma (P = 0.001) than usual-care patients. Providers were also significantly more likely to educate intervention patients about the purpose of their medications (P = 0.03) and side effects (P = 0.001) than usual-care patients. Providers only educated 29% of patients about adherence (33% of intervention group patients and 25% of usual-care patients). Few providers educated patients about barriers and fears/concerns in using glaucoma medications, the cost of medications and insurance coverage, how to administer eye drops, and nasolacrimal occlusion.
The intervention significantly increased provider education about many glaucoma and glaucoma medication topics.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
本研究的目的是进行一项随机对照试验，以测试预诊青光眼视频/问题提示清单干预的有效性，并研究其对提供者在就诊期间向黑人患者讲解青光眼和青光眼药物相关主题的频率的影响。
青光眼问题提示清单/视频干预的随机对照试验。
被诊断为青光眼、正在服用 1 种或多种青光眼药物且报告不遵医嘱的黑人患者。
共纳入 189 名黑人青光眼患者，他们被分配到常规护理组或干预组，在干预组中，患者观看强调提问重要性的视频，并收到一份青光眼问题提示清单，以便在就诊前完成。就诊过程进行录音，患者在就诊后接受访谈。
提供者是否讲解不同的青光眼和青光眼药物相关主题。
干预组患者更有可能向提供者询问 1 个或多个关于青光眼及其治疗的问题。与常规护理组患者相比，提供者更有可能向干预组患者讲解其诊断（P=0.001）、眼内压（P=0.03）、长期治疗必要性的可能性（P=0.001）以及与青光眼相关的身体变化（P=0.001）。与常规护理组患者相比，提供者也更有可能向干预组患者讲解药物的目的（P=0.03）和副作用（P=0.001）。只有 29%的患者（干预组患者占 33%，常规护理组患者占 25%）接受过关于遵医嘱的教育。很少有提供者向患者讲解使用青光眼药物的障碍和担忧/顾虑、药物成本和保险覆盖范围、如何滴眼药水以及鼻泪管阻塞等问题。
该干预措施显著增加了提供者对许多青光眼和青光眼药物相关主题的教育。
本文末尾的脚注和披露中可能包含专有或商业信息。
